Position in SABS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$70,546
+$70,213 QoQ
Shares Held
18,089
+20692.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 86 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. SABS ranks #286 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in SABS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,546 | 18,089 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $333 | 87 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,442 | 1,990 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $174 | 87 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $152 | 87 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $139 | 103 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $398 | 105 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $285 | 106 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $327 | 106 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $471 | 104 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $654 | 951 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $583 | 927 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $731 | 881 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $387 | 881 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $1 | 881 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,840 | 2,625 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,621 | 1,808 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $18,800 | 5,000 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 SABSW | — | 18,347 | Principal | Defined | 2022-02-11 | |
| 2021-12-31 | $29,927 | 3,832 | Shares | Defined | 2022-02-11 | |
| 2021-06-30 BCYP | — | 26,916 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 BCYP | — | 26,916 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||